IT, pharma may lead mkt; see dismal Q2 earnings: HSBC

Fed tapering will take place in a gradual manner and a vicious sell-off in makets is unlikely, says Jitendra Sriram, managing direction and head of research, HSBC India.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney SME Special
moneycontrol.com

Home » News » Markets » FII View

Sep 18, 2013, 05.39 PM | Source: CNBC-TV18

IT, pharma may lead mkt; see dismal Q2 earnings: HSBC

Fed tapering will take place in a gradual manner and a vicious sell-off in makets is unlikely, says Jitendra Sriram, managing direction and head of research, HSBC India.

Like this story, share it with millions of investors on M3

IT, pharma may lead mkt; see dismal Q2 earnings: HSBC

Fed tapering will take place in a gradual manner and a vicious sell-off in makets is unlikely, says Jitendra Sriram, managing direction and head of research, HSBC India.

Post Your Comments

Share Cancel

Jitendra Sriram (more)

MD & Head of Research, HSBC India | Capital Expertise: Equity - Fundamental

Export-oriented sectors IT and pharma, which are seen as major beneficiaries of rupee's steep fall, may continue to lead the Indian equity market, says Jitendra Sriram, managing direction and head of research, HSBC India. Speaking to CNBC-TV18, Sriram says that the Q2 earnings are, however, likely to disappoint. He expects about 6-7 percent growth in Sensex Q2 earnings.

On the imminent event of Fed tapering its bonad buying program, Sriram believes that the monetary stimulus will take place in a gradual manner and a vicious sell-off in markets is unlikely.

“I don’t think that in the near-term one could see something vicious happening because from whatever statements have come out so far, it seems to be more a calibrated approach to an unwind. So to that extent, it will be very modular. They will keep on seeing data probably trying to tinker this process of unwind to as smooth a fashion as possible,” he highlights.

Also read: Asia business sentiment drops sharply, India optimistic

Below is the edited transcript of Sriram’s interview to CNBC-TV18.

Q: What is your sense? How will you approach trade over the next 48 hours ahead of tapering?

A: I would expect the US Fed directionally to go for lower bond purchase. This clearly means that one will see the current account deficit (CAD) extending and India is definitely very vulnerable on that count. In fact, within ASEAN markets, India probably has a lowest Fx cover overall within ASEAN. In case there is any kind of bond buying easing coming through from the Fed then we will see capital flows getting stumped a little bit. 

Q: Do you think because of all this volatility, this market will continue to be just a traders market and very difficult for investors to put in money at any given point?

A: I would say that it is a little bit like a barbell in that regard. In a sense, we have one section which has done very well and that is the exporter segment. If one looks at it, over the last five years, most of the exporting stocks whether it is in the pharmaceutical or IT services, they all made incredible amounts of money for investors.

But typically these are not the stocks, which most traders tend to own and have probably not ended up participating in the rally. The second half has been the entire domestic facing sectors, which have probably struggled all through this while because of the fact that India’s economy has been decelerating.

To put it in another perspective, whatever the US Fed is doing, it is probably going to lead to a little bit more polarisation in the near-term because one will end up wanting to play DM exposures out of an emerging market. So to that extent, one will probably again end up playing the IT, the healthcare and so on in the near-term.

Q: What are the chances of something vicious happening after the FOMC meet, May 22, June 19 something like that, is a big vicious round of sell off in India possible?

A: I don’t think that in the near-term one could see something vicious happening because from whatever statements have come out so far, it seems to be more a calibrated approach to an unwind. So to that extent, it will be very modular. They will keep on seeing data probably trying to tinker this process of unwind to as smooth a fashion as possible. So, to that extent, I would not expect something like a step function correction or a step function upheaval in the market. Those kind of events are highly unlikely.

It will be more gradual in its overall play out. However, India on its own will probably have earning season being a little bit of a disappointment because we are going through a slowdown phase in the economy and to that extent, I think market is still not grasping what could be the extent of slowdown which comes through in terms of corporate earnings.

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
IT, pharma may lead mkt; see dismal Q2 earnings: HSBC

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login